Bifogade filer
Kurs
-3,41%
Kurs
-3,41%
Open
3,00
High
3,06
Low
2,86
Close
2,89
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
5,48 MNOK
Likviditet
5,48 MNOK
Rel. mcap
0,60%
Antal aktier
1 863 743
Likviditet under dagen för detta pressmeddelande
Kalender
Tid* | ||
2026-02-25 | 06:30 | Bokslutskommuniké 2025 |
2025-11-26 | 00:00 | Kvartalsrapport 2025-Q3 |
2025-08-20 | 00:00 | Kvartalsrapport 2025-Q2 |
2025-05-22 | N/A | Årsstämma |
2025-05-14 | 00:00 | Kvartalsrapport 2025-Q1 |
2025-02-26 | 06:30 | Bokslutskommuniké 2024 |
2024-11-27 | - | Kvartalsrapport 2024-Q3 |
2024-08-21 | - | Kvartalsrapport 2024-Q2 |
2024-05-21 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
2024-05-16 | - | Årsstämma |
2024-05-14 | - | Kvartalsrapport 2024-Q1 |
2024-02-28 | - | Bokslutskommuniké 2023 |
2023-11-15 | - | Kvartalsrapport 2023-Q3 |
2023-08-23 | - | Kvartalsrapport 2023-Q2 |
2023-05-16 | - | Kvartalsrapport 2023-Q1 |
2023-05-12 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
2023-05-11 | - | Årsstämma |
2023-02-28 | - | Bokslutskommuniké 2022 |
2022-11-23 | - | Kvartalsrapport 2022-Q3 |
2022-08-24 | - | Kvartalsrapport 2022-Q2 |
2022-05-16 | - | Kvartalsrapport 2022-Q1 |
2022-05-13 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
2022-05-12 | - | Årsstämma |
2022-03-31 | - | Bokslutskommuniké 2021 |
2021-12-22 | - | Extra Bolagsstämma 2021 |
2021-11-17 | - | Kvartalsrapport 2021-Q3 |
2021-08-26 | - | Kvartalsrapport 2021-Q2 |
2021-05-12 | - | Kvartalsrapport 2021-Q1 |
2021-05-06 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
2021-05-05 | - | Årsstämma |
2021-04-21 | - | Bokslutskommuniké 2020 |
2020-11-17 | - | Kvartalsrapport 2020-Q3 |
2020-08-27 | - | Kvartalsrapport 2020-Q2 |
2020-07-07 | - | Split NYKD 1:5 |
2020-07-06 | - | Extra Bolagsstämma |
2020-05-12 | - | Kvartalsrapport 2020-Q1 |
2020-04-22 | - | Extra Bolagsstämma |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2024-12-20 14:19:44
Oslo, Norway, December 20, 2024
Caaby AS has today acquired 100,000 shares in Nykode Therapeutics ASA at an
average price of NOK 3.0 per share. Christian Åbyholm is the 100% owner of Caaby
AS and is a Member of the Board of Directors and primary insider in Nykode
Therapeutics ASA. Following the transaction Caaby AS holds 2,155,295 shares in
Nykode Therapeutics ASA.
Christian Åbyholm has today sold 100,000 shares in Nykode Therapeutics ASA at an
average price of NOK 3.0 per share. Christian Åbyholm is a Member of the Board
of Directors and primary insider in Nykode Therapeutics ASA. Following the
transaction Christian Åbyholm holds 0 shares in Nykode Therapeutics ASA.
For further details, please see the attached form.